Royalty Pharma plc

Healthcare · Biotechnology · United States

Last price 67.18 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 38.63B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company has research and development funding collaboration to advance the development of JNJ-4804, an investigational medicine for autoimmune ...